Ignite Creation Date:
2025-12-24 @ 12:36 PM
Ignite Modification Date:
2026-01-08 @ 1:38 PM
Study NCT ID:
NCT01719861
Status:
TERMINATED
Last Update Posted:
2017-04-17
First Post:
2012-10-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
Sponsor:
Joel Neal
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-29
First Submit QC Date:
None
Study First Post Date:
2012-11-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-12
Results First Submit QC Date:
None
Results First Post Date:
2017-04-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-02
Last Update Post Date:
2017-04-17
Last Update Post Date Type:
ACTUAL